NCT01069562

Brief Summary

With the advancement in microprocessor technology and better understanding of pharmacodynamics and pharmacokinetics of anaesthetic agents, computer facilitated closed loop control of anaesthesia using propofol has been shown to be accurate with better performance than manual control. Literature on computer controlled administration of inhalational anaesthetics is few, as it requires the computer to control the dial setting on the vapouriser. The investigators intend to compare the computer controlled closed loop administration of isoflurane by infusing it into the anaesthetic circuit with conventional vaporiser control in elective open heart surgery. 40 patients (ASA (American Society of Anesthesiology) class II-IV; 18- 65 years) undergoing elective cardiac surgery requiring cardiopulmonary bypass (CPB) will be randomly divided into manual or closed loop groups. Propofol will be used for induction of anaesthesia in both groups followed by isoflurane for maintenance. In the manual group, isoflurane will be administered through the Tech 7 vapouriser during pre and post CPB periods to target bispectral index (BIS) of 50. In closed loop group, isoflurane will be administered using infusion of liquid isoflurane into expiratory limb of the closed circuit. This rate of infusion though a conventional syringe pump will be controlled by algorithm termed 'Improvised Anaesthetic Agent Delivery System' (IAADS) to maintain BIS of 50. Patients in both groups will receive 500ml of 100 % oxygen as fresh gas flow. The % of time bispectral index (BIS) is within the 10 of set target BIS of 50 will be the primary outcome measure. The secondary outcome measures will be median performance error (MDPE)(2), median absolute performance error (MDAPE)(2), wobble(2), divergence(2), amount of isoflurane used and hemodynamic parameters will be secondary outcome measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 1, 2010

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 17, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
9 months until next milestone

Results Posted

Study results publicly available

February 21, 2011

Completed
Last Updated

February 21, 2011

Status Verified

July 1, 2010

Enrollment Period

1.4 years

First QC Date

February 1, 2010

Results QC Date

August 2, 2010

Last Update Submit

January 24, 2011

Conditions

Keywords

closed loop control of anesthesiaisofluraneopen heart surgery

Outcome Measures

Primary Outcomes (1)

  • Percentage of Time Bispectral Index Remains Within 10 of Target BIS of 50

    The duration of time depth of anesthesia was maintained in the recommended range (as measured by BIS) during the period isoflurane (general anesthetic) was administered to the study population. This value expressed as percentage is the primary outcome. BIS is an objective measure of depth of anesthesia derived from statistical(bispectral) analysis of electroencephalographic waves. BIS ranges from 0 to 100. It decreases monotonically from 100 in the awake state to lower values with sedation and anesthesia.

    8 hours (approximately)

Secondary Outcomes (9)

  • Median Performance Error (MDPE)

    8 hours (approximately)

  • Median Absolute Performance Error (MDAPE)

    8 hours (approximately)

  • Wobble

    8 hours (approximately)

  • Percentage of Time Heart Rate Remained Within 25% of Pre-op Baseline

    8 hours (approximately)

  • Percentage of Time Mean Arterial Pressure Remained Within 25% of Pre-op Baseline

    8 hours (approximately)

  • +4 more secondary outcomes

Study Arms (2)

MANUAL

ACTIVE COMPARATOR

In the manual group isoflurane was administered using Tech 7 vapouriser. The dial setting was controlled by the anesthesiologist to achieve and maintain a BIS of 50 during anesthesia.

Other: Conventional control

IAADS group

EXPERIMENTAL

In this group, liquid isoflurane was injected into the circuit using a syringe pump controlled by the IAADS system.The IAADS system has the algorithm to regulate the rate of infusion of isoflurane such that BIS is achieved and maintained at 50 during anesthesia.

Other: Closed loop control

Interventions

The isoflurane administration to deliver anesthesia will be done conventionally through a Tec 7 vaporiser to maintain the bispectral index at 50.

Also known as: MANUAL CONTROL
MANUAL

The isoflurane administration to maintain anesthesia will be by infusion to the anesthesia circuit using syringe pump (injection technique). The rate of delivery of isoflurane will be regulated by computer that uses a control algorithm.

Also known as: AUTOMATED CONTROL
IAADS group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiology physical status 2- 4
  • elective open heart surgery under general anaesthesia
  • requiring Cardio Pulmonary Bypass (CPB)

You may not qualify if:

  • body weight ±30% of the ideal body weight
  • neurological disorder
  • use of any psychoactive medication
  • severe stenotic valve lesions
  • severe pulmonary artery hypertension
  • Tetrology of Fallot repair and other cyanotic heart diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Post graduate institute of medical education and research

Chandigarh, 160012, India

Location

Related Publications (5)

  • Locher S, Stadler KS, Boehlen T, Bouillon T, Leibundgut D, Schumacher PM, Wymann R, Zbinden AM. A new closed-loop control system for isoflurane using bispectral index outperforms manual control. Anesthesiology. 2004 Sep;101(3):591-602. doi: 10.1097/00000542-200409000-00007.

    PMID: 15329583BACKGROUND
  • Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm. 1992 Feb;20(1):63-94. doi: 10.1007/BF01143186.

    PMID: 1588504BACKGROUND
  • Agarwal J, Puri GD, Mathew PJ. Comparison of closed loop vs. manual administration of propofol using the Bispectral index in cardiac surgery. Acta Anaesthesiol Scand. 2009 Mar;53(3):390-7. doi: 10.1111/j.1399-6576.2008.01884.x.

    PMID: 19243324BACKGROUND
  • Puri GD, Kumar B, Aveek J. Closed-loop anaesthesia delivery system (CLADS) using bispectral index: a performance assessment study. Anaesth Intensive Care. 2007 Jun;35(3):357-62. doi: 10.1177/0310057X0703500306.

    PMID: 17591128BACKGROUND
  • Madhavan JS, Puri GD, Mathew PJ. Closed-loop isoflurane administration with bispectral index in open heart surgery: randomized controlled trial with manual control. Acta Anaesthesiol Taiwan. 2011 Dec;49(4):130-5. doi: 10.1016/j.aat.2011.11.007. Epub 2011 Dec 22.

Results Point of Contact

Title
Puri GD
Organization
Post Graduate Institute of Medical Education and Research

Study Officials

  • Puri GD, MBBS MD PhD

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR
  • Sethu Madhavan, MBBS

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR
  • Preethy J Mathew, MBBS, MD

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 1, 2010

First Posted

February 17, 2010

Study Start

January 1, 2009

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

February 21, 2011

Results First Posted

February 21, 2011

Record last verified: 2010-07

Locations